Login / Signup

Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer.

Xiaoliang ChenJinghui LiuLijun ChengChaohao LiZhuangzhuang ZhangYunfeng BaiRuixin WangTao HanChangkun HuangYifan KongFeng FengXiaoqi Liu
Published in: The Prostate (2019)
The noncanonical Wnt pathway is activated in enzalutamide-resistant PCa and inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance and enhances its efficacy in CRPC.
Keyphrases
  • prostate cancer
  • cell proliferation
  • stem cells